EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

THE ROLE OF VITAMIN D SUPPLEMENTATION IN REDUCING COVID-19 SEVERITY IN CHILDREN: A NARRATIVE REVIEW

Iryna Vyshnytska, Viktoriia Svyrydovska, Minerva Hernandez, Brian Golbodaghi

Bulletin of medicine, psychology and pharmacy · 2025

DOI: 10.20998/bmpp.2024.02.09 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of medicine, psychology and pharmacy, 2025. Verfasst von Iryna Vyshnytska und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction. Vitamin D3 supplementation has been shown to play an important role in the immune response and protection against COVID-19 infection in all populations [1] but the effects of Vitamin D3 supplementation in pediatric patients infected with COVID-19 is yet to be explored. In this narrative review we studied the effects of 25‐hydroxycholecalciferol (25‐OHD) in children infected with COVID-19. Purpose of the study. This secondary research aims to execute a search in the literature to identify the data regarding vitamin D3 supplementation and the severity of COVID-19 infection in children aged 1-18. This will allow us to determine if there is any correlation with vitamin D3 supplementation at higher doses with a reduction in COVID-19 mortality, duration of infection, etc. Materials and methods. A comprehensive review of the literature located within electronic databases was conducted to identify relevant studies. Databases used include PubMed and Google Scholar. Studies were selected which met the inclusion criteria. Data extraction and quality assessment was performed using standardized methods. The studies required subjects aged 1-18 infected with COVID-19 and serum vitamin D3 levels. Some studies compiled into our review also included the severity of symptoms. Only studies published in the English language were included. The results. The literature revealed correlations between vitamin D3 levels in children aged 1-18 years infected with COVID-19 and the severity of infection. There was a linear relationship between lower vitamin D3 levels and the increased severity of COVID-19 infection in pediatric patients. These results suggest that vitamin D3 should be supplemented to potentially be able to decrease the severity of COVID-19 infection in a pediatric patient population or as a prophylaxis to COVID-19 infection. However, serum levels are to be detected in what is used for the amount of vitamin D3 to show how much is needed to reduce the severity of COVID-19.

Zitieren

APA

Vyshnytska, I., Svyrydovska, V., Hernandez, M., & Golbodaghi, B. (2025). THE ROLE OF VITAMIN D SUPPLEMENTATION IN REDUCING COVID-19 SEVERITY IN CHILDREN: A NARRATIVE REVIEW. Bulletin of medicine, psychology and pharmacy. https://doi.org/10.20998/bmpp.2024.02.09

Vancouver

Vyshnytska I, Svyrydovska V, Hernandez M, Golbodaghi B. THE ROLE OF VITAMIN D SUPPLEMENTATION IN REDUCING COVID-19 SEVERITY IN CHILDREN: A NARRATIVE REVIEW. Bulletin of medicine, psychology and pharmacy. 2025. doi:10.20998/bmpp.2024.02.09

BibTeX
@article{Vyshnytska2025,
  author = {Vyshnytska, Iryna and Svyrydovska, Viktoriia and Hernandez, Minerva and Golbodaghi, Brian},
  title = {THE ROLE OF VITAMIN D SUPPLEMENTATION IN REDUCING COVID-19 SEVERITY IN CHILDREN: A NARRATIVE REVIEW},
  journal = {Bulletin of medicine, psychology and pharmacy},
  year = {2025},
  doi = {10.20998/bmpp.2024.02.09}
}
Kostenlos starten →